Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stuart J Peacock

Showing results (11-20 of 44) with videos related to

Pageof 5
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 11, 2010
Severity as an independent determinant of the social value of a health serviceJeff R J Richardson, John McKie, Stuart J Peacock, et al.
The Oncologist|July 13, 2016
Cost-Effectiveness Analysis of Using Loss of Heterozygosity to Manage Premalignant Oral Dysplasia in British Columbia, CanadaIan Cromwell, Dean A Regier, Stuart J Peacock, et al.
Journal of Cancer Policy|May 13, 2022
Health-related quality of life data collected in chimeric antigen receptor T-cell (CAR-T) therapy clinical trialsAdam J N Raymakers, Dean A Regier, Stuart J Peacock, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|May 18, 2017
The Girls-Only HPV Vaccination Program in British Columbia, Canada: A Qualitative Study Exploring Expert Informants' Perspectives of Input From the PublicHelen McTaggart-Cowan, Colene Bentley, Gina Ogilvie, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 19, 2010
Priority setting in healthcare: towards guidelines for the program budgeting and marginal analysis frameworkStuart J Peacock, Craig Mitton, Danny Ruta, et al.
The Oncologist|June 3, 2015
A Time-Trend Economic Analysis of Cancer Drug TrialsSonya Cressman, George P Browman, Jeffrey S Hoch, et al.
Healthcare Management Forum|October 25, 2019
Evidence, values, and funding decisions in Canadian cancer systemsStuart J Peacock, Dean A Regier, Adam J N Raymakers, et al.
BMC Health Services Research|May 10, 2018
Trade-offs, fairness, and funding for cancer drugs: key findings from a deliberative public engagement event in British Columbia, CanadaColene Bentley, Sarah Costa, Michael M Burgess, et al.
Pharmacoeconomics|January 19, 2021
Early-Phase Clinical Trials and Reimbursement Submissions to the Pan-Canadian Oncology Drug ReviewAdam J N Raymakers, Kristina M Jenei, Dean A Regier, et al.
Health and Quality of Life Outcomes|April 18, 2012
Construction of the descriptive system for the Assessment of Quality of Life AQoL-6D utility instrumentJeffrey R J Richardson, Stuart J Peacock, Graeme Hawthorne, et al.
Pageof 5

Showing results (11-20 of 44) with videos related to

Sort By:
Pageof 5
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|May 11, 2010
Severity as an independent determinant of the social value of a health serviceJeff R J Richardson, John McKie, Stuart J Peacock, et al.
The Oncologist|July 13, 2016
Cost-Effectiveness Analysis of Using Loss of Heterozygosity to Manage Premalignant Oral Dysplasia in British Columbia, CanadaIan Cromwell, Dean A Regier, Stuart J Peacock, et al.
Journal of Cancer Policy|May 13, 2022
Health-related quality of life data collected in chimeric antigen receptor T-cell (CAR-T) therapy clinical trialsAdam J N Raymakers, Dean A Regier, Stuart J Peacock, et al.
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC|May 18, 2017
The Girls-Only HPV Vaccination Program in British Columbia, Canada: A Qualitative Study Exploring Expert Informants' Perspectives of Input From the PublicHelen McTaggart-Cowan, Colene Bentley, Gina Ogilvie, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|October 19, 2010
Priority setting in healthcare: towards guidelines for the program budgeting and marginal analysis frameworkStuart J Peacock, Craig Mitton, Danny Ruta, et al.
The Oncologist|June 3, 2015
A Time-Trend Economic Analysis of Cancer Drug TrialsSonya Cressman, George P Browman, Jeffrey S Hoch, et al.
Healthcare Management Forum|October 25, 2019
Evidence, values, and funding decisions in Canadian cancer systemsStuart J Peacock, Dean A Regier, Adam J N Raymakers, et al.
BMC Health Services Research|May 10, 2018
Trade-offs, fairness, and funding for cancer drugs: key findings from a deliberative public engagement event in British Columbia, CanadaColene Bentley, Sarah Costa, Michael M Burgess, et al.
Pharmacoeconomics|January 19, 2021
Early-Phase Clinical Trials and Reimbursement Submissions to the Pan-Canadian Oncology Drug ReviewAdam J N Raymakers, Kristina M Jenei, Dean A Regier, et al.
Health and Quality of Life Outcomes|April 18, 2012
Construction of the descriptive system for the Assessment of Quality of Life AQoL-6D utility instrumentJeffrey R J Richardson, Stuart J Peacock, Graeme Hawthorne, et al.
Pageof 5